CompaniesByCap
ADPT
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare

Adaptive Biotechnologies Corporation Income Statement 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenues
Revenue277.0M179.0M170.3M185.3M154.3M98.4M85.1M55.7M38.4M
Gross Profit205.6M106.9M94.7M127.4M105.0M75.9M62.8M36.0M22.8M
Profitability
Operating Income-57.1M-162.5M-227.0M-200.2M-209.0M-152.8M-78.4M-49.8M-44.5M
EBITDA-41.1M-145.1M-207.4M-179.3M
Net Income-59.5M-159.5M-225.3M-200.2M-207.3M-146.2M-68.6M-46.4M-42.8M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)152M147M144M143M140M131M125M13M

Adaptive Biotechnologies Corporation Income Statement — FAQ

Adaptive Biotechnologies Corporation (ADPT) income statement over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ADPT's income statement history?

The chart and table above show Adaptive Biotechnologies Corporation's income statement by year and by quarter, including the growth rate.